Evidence map›Paper›PMID 33317611›Full record

ArticleBMC research notes2020

A plasmid-encoded papB paralogue modulates autoaggregation of Escherichia coli transconjugants.

Rubén Monárrez, Iruka N Okeke

Open access · goldAbstract read
In one paragraph

Article in BMC research notes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 67% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Rubén MonárrezDepartment of Biology, Haverford College, Haverford, Pennsylvania, USA.
Iruka N OkekeDepartment of Biology, Haverford College, Haverford, Pennsylvania, USA. iruka.n.okeke@gmail.com.ORCID http://orcid.org/0000-0002-1694-7587
Haverford College · US

Funding

Medical Research Council MR/L00464X/1National Science Foundation (US) 0948460Society in Science The Brano Weiss Fellowship
6 · The paper itself

Abstract

objectivePlasmids are key to antimicrobial resistance transmission among enteric bacteria. It is becoming increasingly clear that resistance genes alone do not account for the selective advantage of plasmids and bacterial strains that harbor them. Deletion of a 32 Kb fitness-conferring region of pMB2, a conjugative resistance plasmid, produced a hyper-autoaggregation phenotype in laboratory Escherichia coli. This study sought to determine the genetic basis for hyper-autoaggregation conferred by the pMB2-derived mini-plasmid.

resultsThe 32 Kb fragment deleted from pMB2 included previously characterized nutrient acquisition genes as well as putative transposase and integrase genes, a 272 bp papB/ pefB-like gene, and several open-reading frames of unknown function. We cloned the papB/ pefB paralogue and found it sufficient to temper the hyper-autoaggregation phenotype. Hyper-autoaggregation conferred by the mini-plasmid did not occur in a fim-negative background. This study has identified and characterized a gene capable of down-regulating host adhesins and has shown that trans-acting papB/pefB paralogues can occur outside the context of an adhesin cluster. This plasmid-mediated modification of a bacterial host's colonization program may optimize horizontal transfer of the mobile element bearing the genes.

Indexed as

Escherichia coliEscherichia coli ProteinsAdhesins, BacterialBacterial Outer Membrane ProteinsConjugation, GeneticIntegrasesPlasmidsAdhesins, BacterialBacterial Outer Membrane ProteinsEscherichia coli ProteinsIntegrasestraN protein, E coliAutoaggregationFimbrial regulationPapBPefBPlasmid

Identifiers

PMID33317611
PMCPMC7734786
OpenAlexW3110268654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.